# Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.

> **NCT00434681** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 48 (—)

## Conditions studied

- Fever
- Pain

## Interventions

- **DRUG:** paracetamol 4.8% paediatric oral suspension

## Key facts

- **NCT ID:** NCT00434681
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 48 (—)
- **Last updated:** 2008-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434681, "Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00434681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*